絞り込み

16735

広告

京大霊長類研の教授ら4人 5億円余を不正支出 大学が報告書 (NHK)

サルの研究で世界的に有名な京都大学霊長類研究所の教授ら4人が、研究費5億円余りを不正に支出していたとする調査報告書を京都大学がまとめたことが分かりました。 研究...

  1. ノーベル賞受賞の物性物理の泰斗、アンダー...
  2. ノーベル賞受賞の物性物理の泰斗、アンダー...
  3. 海底の岩、人間の腸内並み微生物 (デイリ...
  4. 新型コロナウイルス感染症の患者等の発生に...

ニュース一覧

「vildagliptin」の検索結果

1082件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Cardiovascular safety and effectiveness of vildagliptin in patients with type 2 diabetes mellitus: a 3-year, large-scale post-marketing surveillance in Japan.

Vasculoprotective Effects of Vildagliptin. Focus on Atherogenesis.

Dipeptidyl peptidase 4 inhibitors linked bullous pemphigoid in patients with type 2 diabetes mellitus: A series of 13 cases.

The paradox of dipeptidyl peptidase IV inhibition in enterocytic differentiation and epithelial-mesenchymal transition in rat cholestatic sepsis.

Bullous pemphigoid associated with the use of dipeptidil peptidase-4 inhibitors: analysis from studies based on pharmacovigilance databases.

When does diabetes start? Early detection and intervention in type2 diabetes mellitus.

Renoprotective effect of vildagliptin following hepatic ischemia/reperfusion injury.

Atorvastatin attenuates obese-induced kidney injury and impaired renal organic anion transporter 3 function through inhibition of oxidative stress and inflammation.

Aberrant expression of miR-214 is associated with obesity-induced insulin resistance as a biomarker and therapeutic.

Impact of some oral hypoglycemic agents on type 2 diabetes-associated depression and reserpine-induced depression in rats: the role of brain oxidative stress and inflammation.

Phytochemicals in Garlic Extract Inhibit Therapeutic Enzyme DPP-4 and Induce Skeletal Muscle Cell Proliferation: A Possible Mechanism of Action to Benefit the Treatment of Diabetes Mellitus.

Effect of Adding Vildagliptin to Insulin in Hemodialyzed Patients with Type 2 Diabetes: A Randomized Multicentric Prospective Study-The VILDDIAL Study.

A clinical case of bullous pemphigoid induced by vildagliptin.

Efficacy of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion (CSII) in Hospitalized Patients with Type 2 Diabetes.

Cognitive and metabolic outcomes of vildagliptin addition to the therapy in patients with type 2 diabetes mellitus: 26 week follow-up study.

Effectiveness, safety, and tolerability of vildagliptin or vildagliptin/metformin combination in patients with type 2 diabetes uncontrolled on insulin therapy in a real-world setting in Egypt: the OMEGA study.

Risk of cancer in patients treated with dipeptidyl peptidase-4 inhibitors: an extensive meta-analysis of randomized controlled trials.

Pharmacological Intervention for Diabetes After Pregnancy Prevention in Women with Prior Gestational Diabetes: A Scoping Review.

Vildagliptin-induced ground-glass nodules mimicking lung metastases in a cancer patient receiving Lactobacillus probiotic supplementation.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります